In the shear stress-induced endothelial dysfunction (atherosclerosis model) tested on human aortic endothelial cells (HAECs) [79], juglanin treatment resulted in the downregulation of NOX-2 (NADPH oxidase 2) and reduction of intracellular ROS levels. This evidence concerns the gene CYBB and atherosclerosis.